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Background: The field of biomarker discovery, development and application has been the subject of intense
interest and activity, especially with the recent emergence of new technologies, such as proteomics-based
approaches. In proteomics, search for biomarkers in biological fluids such as human serum is a challenging issue,
mainly due to the high dynamic range of proteins present in these types of samples. Methods for reducing the
content of most highly abundant proteins have been developed, including immunodepletion or protein
equalization. In this work, we report for the first time the combination of a chemical sequential depletion method
based in two protein precipitations with acetonitrile and DTT, with a subsequent two-dimensional difference in-gel
electrophoresis (2D-DIGE) analysis for the search of osteoarthritis (OA) biomarkers in human serum. The depletion
method proposed is non-expensive, of easy implementation and allows fast sample throughput.
Results: Following this workflow, we have compared sample pools of human serum obtained from 20 OA patients
and 20 healthy controls. The DIGE study led to the identification of 16 protein forms (corresponding to 14 different
proteins) that were significantly (p < 0.05) altered in OA when compared to controls (8 increased and 7 decreased).
Immunoblot analyses confirmed for the first time the increase of an isoform of Haptoglobin beta chain (HPT) in
sera from OA patients.
Conclusions: Altogether, these data demonstrate the utility of the proposed chemical sequential depletion for the
analysis of sera in protein biomarker discovery approaches, exhibit the usefulness of quantitative 2D gel-based
strategies for the characterization of disease-specific patterns of protein modifications, and also provide a list of OA
biomarker candidates for validation.Background
In clinical proteomics, searching for protein biomarkers
is currently done using mass spectrometry-based tools
coupled to chromatography or to gel electrophoresis
techniques. The samples most commonly used for bio-
marker discovery are plasma and serum, due to their
easy availability. It is generally agreed that each of these
samples have more than ten thousand different proteins.
From such large amount, it is estimated that circa 20
proteins account for more than 95% of the bulk mass of
all proteins [1,2]. These large abundant proteins hinder
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distribution, and reproduction in any mediumsignals belonging to such proteins mask those from
other less abundant, yet more important proteins in
terms of information related to diseases. Therefore, re-
moval of the most abundant proteins helps to overcome
the aforementioned problem. However, to date there is
no universal method to accomplish this task. Therefore,
many different protocols to deplete high abundant pro-
teins can be found in literature comprising, but not lim-
ited to: (i) HPLC columns containing antibodies to the
most abundant proteins, (ii) spin columns, (iii) the use
of chemical reagents, (iv) or even sophisticated kits used
to compress the dynamic range of the proteins rather
than to deplete them [3-5].
Recently, the use of non-expensive chemical reagents
as a way to deplete high abundance proteins has
attracted the attention of the proteomics community
[6,7]. Furthermore, it has been suggested to link the usetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Workflow of the strategy performed for the
DIGE-based quantitative differential proteomic analysis on
human sera.
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tion. For instance, serum depleted with DTT was found
rich in IgG-type proteins and for this reason it has been
proposed as an economic method in studies of diseases
that are characterized by modifications in the IgG-type
protein content, such as multiple myeloma [8]. After de-
pletion, the resulting proteome is investigated for bio-
marker discovery using different methodologies,
including gel electrophoresis. Two-dimensional differ-
ence in gel electrophoresis, 2D-DIGE, has emerged has a
powerful tool in proteomics. In 2D-DIGE, complex pro-
tein samples are labeled with different fluorescent dyes,
mixed together and separated in the same gel. This
method solves the problem of gel-to-gel variation [9],
and allows for high sample throughput as only one gel is
needed to perform the comparisons and spot intensities
can be normalized against a unique internal standard.
The present work reports for the first time the com-
bination of a chemical sequential depletion method
combined with 2D-DIGE for the search of osteoarthritis
biomarkers. Osteoarthritis is a degenerative joint disease
characterized by cartilage destruction and bone changes,
occasionally accompanied by synovial inflammation [10].
It is the most common rheumatic pathology, and esti-
mates are that the number of people with some degree
of OA will double over the next three decades [11]. Des-
pite this high prevalence, existing diagnostic tests are
very limited and ultimately rely on the subjective de-
scription of pain symptoms, stiffness in the affected
joints, and radiography [12]. These limitations have
increased the interest in identifying new specific bio-
logical markers for cartilage degradation, both to facili-
tate early diagnosis of joint destruction and to improve
the prognosis and evaluation of disease progression. Be-
sides the promising results obtained with some cartilage-
specific proteins, still useful biomarkers are needed for
clinical practice, which could be effective for the develop-
ment of early diagnostic tools and/or alternative therapies
[13]. The method proposed of sequential depletion for
biomarker search in serum samples is non-expensive, of
easy implementation and allows fast sample throughput.
Results and discussion
This work illustrates the application of a chemical se-
quential depletion method in quantitative proteomics
studies for biomarker discovery. The search of novel bio-
markers is an area in which proteomics has recently
emerged as a powerful approach for the detection of
new proteins with diagnostic, prognostic or therapy
evaluation utilities. In this field, a number of proteomics
experiments have been followed in the last years with
the aim of characterizing novel molecules with bio-
marker power for joint diseases, including osteoarthritis
(OA) [14]. In the present study, we report thecombination of a chemical sequential depletion method
combined with 2D-DIGE for the search of OA biomar-
kers. This method reduces the dynamic range of serum
proteins, thus allowing the identification of a higher
number of proteins in the samples.
Sequential depletion of human serum for proteomics
analyses
We have recently reported the comparison of two differ-
ent chemical depletion methods, using acetonitrile or
DTT, with the protein equalization obtained with the
ProteoMiner kit (Bio-Rad) [8] for the mass spectrometry
analysis of human serum proteins. Our results showed
how ACN depletion was efficient for depleting high mo-
lecular weight proteins (over 75 kDa), whereas DTT de-
pletion primarily promotes the precipitation of proteins
rich in disulphide bonds (mainly albumin). In the
present work, we combine these two chemical depletions
in a sequential way, with the aim of simplifying the
serum protein profile while removing high abundant
(usually uninformative) proteins. The workflow followed
for this sequential depletion is showed in Figure 1, and
is fully described in the Methods section. Human sera
were first depleted with DTT, and the supernatant was
further treated with ACN in order to efficiently reduce
the dynamic range of proteins in our samples. The pro-
tein recovery employing this sequential strategy was
2 ± 0.3%, while the use of either DTT or ACN depletion
alone leads to a yield of 32 ± 2% or 4 ± 0.2%, respectively.
To test the reliability of the sequential depletion pro-
cedure, we first performed reproducibility tests by ana-
lyzing five technical replicates (obtained from five
independent depletions of the same serum), and also
three biological replicates (obtained from three inde-
pendent sera). For these analyses, proteins in the
depleted samples were fractionated using C18 NuTips
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concentrations of ACN (from 4% to 60%). By these
means, ten fractions were obtained from each sample,
which were then spotted onto a MALDI plate and ana-
lyzed by MS. Figure 2 demonstrates the high technical
(A) and biological (B) reproducibility that we found on
the sequentially depleted samples, which are also illu-
strated in the gel shown on Figure 2C.
Proteins in the crude (ND) and depleted (D) samples
were separated by one- and two-dimensional gel electro-
phoresis, in order to evaluate the protein profiles of
these two kinds of samples. The different profiles that
were obtained after the sequential depletion are illu-
strated in Figure 3, showing the decrease of high
molecular weight proteins that is characteristic of ACN-
depleted sera, and also the enrichment of some proteins
that were masked by albumin in the crude samples. As
shown in the Figure, with this method we were able to
deplete in an efficient way serum albumin (ALBU) and
other high abundant proteins such as alpha-2-
macroglobulin (A2MG), transferrin (TRFE), Comple-
ment 3α (C3α), or the heavy chain of IgG (IGGγ).
We randomly picked 54 spots from these 2D gels and
identified the protein forms present in each of them,
which correspond to 16 different proteins (Additional
file 1: Figure S1 and Additional file 2: Table S1). Al-
though many of them belong to the most abundantFigure 2 Reproducibility of the sequential depletion method. Technic
MS in order to evaluate the reproducibility. Coloured squares show the ide
(10% acrylamide, silver staining), illustrating the representative protein profi
by duplicate, which further demonstrate the reproducibility of the strategyplasma proteins, as expected for a gel-based technique
(which has an important bias towards abundant pro-
teins), we were also able to identify two proteins that are
reported to be present at less than 1 μmol/L in plasma,
such as serum amyloid A (SAA1) or angiotensinogen
(ANGT) [15]. These results support the usefulness of
the strategy for the study of medium-abundant serum
proteins.
2D-DIGE quantitative proteomics analysis on the
sequentially depleted serum samples
The sequential depletion method was then applied to
study the osteoarthritis-dependent modulation of pro-
teins in serum. Those proteins that are altered in sam-
ples from diseased patients might be useful as OA
biomarkers for diagnostic or prognostic purposes, and
also for the evaluation of alternative therapies.
With this aim, serum samples from 40 patients (20
suffering severe OA and 20 healthy controls) were
grouped into four pools of 10 samples each, to reduce
the individual and biological variability that has been
reported in plasma proteins [16]. Although this involves
the loss of each sample individual data, this pool-
ing strategy has demonstrated its usefulness for bio-
marker discovery in shotgun proteomics approaches
[17]. Table 1 summarizes the characteristics of each
pool. To perform the differential quantitative analysis,al (A) and biological (B) replicates were analyzed by MALDI-TOF/TOF
ntification of each protein on the different replicates. (C) SDS-PAGE gel
les obtained after the sequential depletion of three independent sera
.
Figure 3 Differential protein profile of sequentially depleted serum. One-dimensional (A) and two-dimensional (B) gel electrophoresis
separations, showing the different protein profiles of non-depleted human serum (ND) and serum depleted (D) according to the sequential
method presented in this work. Some of the most representative proteins that are either depleted or typically present in the depleted maps are
depicted. A1AT: alpha-1-antitrypsin; A2MG: alpha-2-macroglobulin; ALBU: serum albumin; APOA1: apolipoprotein A1; APOC3: apolipoprotein C3;
CO3α: complement factor α; HPT: haptoglobin; IGGγ: IgG heavy (gamma) chain; IGGκ/λ: IgG light (kappa/lambda) chains; TRFE: transferrin; TTYH:
transthyretin. In (C), this protein profile is compared to those obtained with ACN and DTT protein depletion methods alone. 1: crude serum, 2:
ACN depletion, 3: DTT depletion, 4: sequential depletion.
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quantitative gel-based approach up to date. It permits
direct quantitative evaluation of changes, reduces inter-
gel variation and false positives [9,19] and therefore
results in highly confident data with biological signifi-
cance. Moreover, one of the advantages of 2D-DIGE ver-
sus non-gel based quantitative proteomics techniques is
that it can directly detect not only changes of protein
quantity, but also posttranslational modifications of theTable 1 Characteristics of the osteoarthritis (OA) patients
and controls included in this study
Control OA
Number of patients 20 20
Agea) 67.75 ± 9.08 75.85 ± 5.00
Proteinb) 57.68 ± 5.06 56.38 ± 4.92
Pool 1 Pool 2
Number of patients 10 10
Age 66.20 ± 8.83 76.10 ± 4.79
Protein 57.69 ± 5.15 54.69 ± 4.50
Pool 3 Pool 4
Number of patients 10 10
Age 69.30 ± 9.52 75.60 ± 5.44
Protein 57.66 ± 5.25 58.07 ± 3.83
a) Age shown as years with mean ± SD.
b) Protein shown in μg/μl with mean ± SD.proteins [20], which are known to be remarkably abun-
dant in serum samples.
The four serum pools were labelled with Cy dyes as
described in Table 2. A technical replicate was per-
formed with each sample by swapping the dye (that is,
the same sample was labelled once with Cy3 and also
with Cy5), in order to avoid labelling artefacts. Sample
pairs were combined with the Cy2-labeled internal
standard, and proteins were resolved by four-plex 2D gel
electrophoresis. The 12 individual images obtained in
this experiment (three from each gel, corresponding to
Cy2-, Cy3- and Cy5-labeled samples) were analyzed with
the SameSpots software, which allowed the normaliza-
tion of spot intensities and the calculation of abundance
ratios and statistical power of the results. All analyzed
images are illustrated in Figure 4. An average of 210 pro-
tein spots were detected and matched on the gel images.
We considered changes within 95% confidence interval
(p < 0.05) and standardized average spot volume ratios
exceeding 1.3.Table 2 DIGE experimental design
Gel 1 Pool 1/Cy3 Pool 2/Cy5
Gel 2 Pool 1/Cy5 Pool 2/Cy3
Gel 3 Pool 3/Cy3 Pool 4/Cy5
Gel 4 Pool 3/Cy5 Pool 4/Cy3
Figure 4 Images from the DIGE gels obtained in this work. The two-dimensional gel images corresponding to the Cy2-, Cy3- and Cy5-
labeled samples are shown.
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in this work
The analysis resulted in 46 spots significantly and repro-
ducibly altered between OA and control samples (29
increased and 17 decreased), which are depicted on the
2D-DIGE gel image shown in Figure 5. For the identifi-
cation of the altered proteins, spots were excised from
the gels, digested in-gel and analysed by MALDI-MS/
MS. Mascot database search using the MS/MS spectraFigure 5 Two-dimensional gel showing the putative OA protein biom
Table 3.allowed the identification of the proteins present in all
the spots. Altogether, these 46 spots correspond to 15
different protein forms that were identified as altered in
OA. These proteins are listed in Table 3 with complete
information comprising experimental and theoretical
MW and pI values, accession number and identification
parameters. A database search was carried out to assign
them into different functional groups, which are also
detailed in Table 3.arkers identified in this work. Protein abbreviations, according to
Table 3 Proteins identified in this work as altered in Osteoarthritis vs Control sera
Protein
IDa)
Acc.No.a) Name Function Ratio
OA:Nb)
Anova
(p)
Predictedc) Experimentald) Scoree) Sequence tagsf)
MW (Da) pI MW (Da) pI
A1AT P01009 Alpha-1-
antitrypsin
Inhibitor of
serine
proteases
1.4 0.008 46878 5.37 40047 5.33 151 K. TDTSHHDQDHPTFNK.I
K. ITPNLAEFAFSLYR.Q
K. QINDYVEKGTQGK.I
K. GKWERPFEVK.D
K. DTEEEDFHVDQVTTVK.V
R. LGMFNIQHCK.K
K. LQHLENELTHDIITK.F
K. FLENEDRR.S
K. VFSNGADLSGVTEEAPLK.L
K. FNKPFVFLMIEQNTK.S
FETUA P02765 Alpha-2-HS-
glycoprotein
Negative
regulation of
bone
mineralization
2 0.004 40098 5.43 40098 5.43 102 K. CNLLAEKQYGFCK.A
R. HTFMGVVSLGSPSGEVSHPR.K
ANGT P01019 Angiotensinogen
Essential component of
the renin-
angiotensin
system (RAS)
1.3 0.001 53406 5.87 40056 5.48 28 K. ANAGKPKDPTFIPAPIQAK.T
APOA1 P02647 Apolipoprotein
A-I
Cholesterol
metabolism
2.2 0.013 30759 5.56 31221 5.43 271 K. DSGRDYVSQFEGSALGK.Q
K. LLDNWDSVTSTFSK.L
K. LLDNWDSVTSTFSKLR.E
K. VQPYLDDFQKK.W
K. KWQEEMELYR.Q
K. WQEEMELYR.Q
K. VEPLRAELQEGAR.Q
K. LSPLGEEMRDR.A
R. THLAPYSDELR.Q
R. THLAPYSDELRQR.L
K. ATEHLSTLSEKAKPALEDLR.Q
K. AKPALEDLR.Q
APOA2 P02652 Apolipoprotein
A-II
Lipid transport 0.7 0.003 11282 6.26 11064 5.23 82 K. VKSPELQAEAK.S
K. SPELQAEAK.S
K. SKEQLTPLIK.K
APOA4 P06727 Apolipoprotein
A-IV
Lipid transport 0.6 0.005 45371 5.28 37738 5.47 37 K. LVPFATELHER.L
R. LEPYADQLR.T
R. TQVNTQAEQLRR.Q
R. QLTPYAQR.M
K. IDQNVEELKGR.L
R. ISASAEELRQR.L
R. LAPLAEDVR.G
R. LAPLAEDVRGNLR.G
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Table 3 Proteins identified in this work as altered in Osteoarthritis vs Control sera (Continued)
K. SLAELGGHLDQQVEEFR.R
K. SLAELGGHLDQQVEEFRR.R
R. RVEPYGENFNK.A
K. ALVQQMEQLR.Q
APOC3 P02656 Apolipoprotein
C-III
Lipid
degradation
and transport
0.8 0.014 10846 5.23 13922 5.16 149 K. TAKDALSSVQESQVAQQAR.G
K. DALSSVQESQVAQQAR.G
HPT P00738 Haptoglobin
(β chain)
Cellular iron
ion
homeostasis
2 0.007 45861 6.13 35377 5.74 90 K. GSFPWQAK.M
R. NANFKFTDHLK.Y
K. YVMLPVADQDQCIR.H
K. SPVGVQPILNEHTFCAGMSK.Y
HPT P00738 Haptoglobin
(α 1 chain)
Cellular iron
ion
homeostasis
1.4 0.006 45861 6.13 19281 5.98 68 R. YQCKNYYK.L
K. LRTEGDGVYTLNNEK.Q
K. AVGDKLPECEAVCGKPK.N
HPT P00738 Haptoglobin
(α 2 chain)
Cellular iron
ion
homeostasis
0.5 0.0002 45861 6.13 28110 5.97 135 R. TEGDGVYTLNDKK.Q
K. LRTEGDGVYTLNNEK.Q
K. AVGDKLPECEAVCGKPK.N
K. AVGDKLPECEAVCGKPK.N
HBB P68871 Hemoglobin
subunit beta
Involved in
oxygen
transport from
the lung to
peripheral
tissues
1.6 0.014 16102 6.75 16102 6.75 43 R. LLVVYPWTQR.F
IGKC P01834 Ig kappa chain
C region
Immune
response
0.6 0.003 11773 5.58 33273 6.42 107 -. TVAAPSVFIFPPSDEQLK.S
K. SGTASVVCLLNNFYPR.E
LAC2 P0CG05 Ig lambda-2
chain C regions
Complement
activation,
classical
pathway
0.6 0.003 11458 6.92 33273 6.42 72 K. AAPSVTLFPPSSEELQANK.A
K. QSNNKYAASSYLSLTPEQWK.S
R. SYSCQVTHEGSTVEK.T
R. SYSCQVTHEGSTVEKTVAPTECS.-
A2GL P02750 Leucine-rich
alpha-2-
glycoprotein
Protein binding
(secreted)
1.5 0.005 38382 6.45 38507 5.47 88 R. YLFLNGNKLAR.V
R. VAAGAFQGLR.Q
R. CAGPEAVKGQTLLAVAK.S
SAA P02735 Serum amyloid
A protein
Acute-phase
response
0.8 0.014 13581 6.28 15299 6.53 52 R.EANYIGSDKYFHAR.G
R.FFGHGAEDSLADQAANEWGR.S
TTHY P02766 Transthyretin Thyroid
hormone-
binding
protein
2.2 0.022 15991 5.52 28287 6.3 136 R.KAADDTWEPFASGK.T
K.AADDTWEPFASGK.T
a) Protein ID and accession number according to SwissProt database.
b) Average volume ratio OA:N, quantified by SameSpots software.
c) Predicted molecular weight (MW) and Isoelectric point (pI) according to protein sequence and SwissProt database.
d) Experimental molecular weight (MW) and Isoelectric point (pI) calculated by analysis of the gel images with SameSpots software.
e) MS protein score obtained from MALDI-TOF/TOF spectra using Mascot search engine.
f) Sequence tags identified by MALDI-TOF/TOF MS/MS.
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from that obtained in a previous work from our group
based on serum immunodepletion and subsequent LC-
MS/MS analysis [21]. In that work, several relatively
high abundant proteins (such as complement compo-
nents) were found increased in the sera from OA
patients. On the contrary, most complement proteins
are removed by the different depletion approach in the
present study, while several apolipoproteins are identi-
fied. This demonstrates the complementarity of different
depletion steps. Furthermore, although the gel-based
strategy performed in this study did not allowed the
identification of less abundant proteins, it demonstrates
its usefulness of for characterizing disease-specific pat-
terns of protein modifications, which are impossible to
obtain from peptide/MS-based strategies. This includes
not only the identification of a specific isoform of HPT
beta chain as increased in OA, but also different forms of
serum amyloid A, transthyretin or some apolipoproteins.
Nevertheless, both proteomic approaches led to the
identification of several ubiquitous proteins related with
lipid transport, immune response or protein binding. Al-
though the molecules that had been employed typically
as OA biomarkers are proteins directly or indirectlyFigure 6 Verification of the OA-dependent alteration of HPT by West
obtained from the DIGE gels, together with the quantitative data acquired
samples). (B) Proteins in crude serum samples from OA patients (n = 15) an
antibodies against HPT. Band intensities were normalized against the inten
densitometric analysis of the blot signals confirmed the increase of HPT beinvolved in cartilage degradation, or proteins synthesized
in an attempt at cartilage repair (including different type
II collagen fragments or other cartilage extracellular
matrix components) [22], increasing evidences suggest
that the most promising strategy in OA would be the
combination of different biomarkers into panels. These
might include proteins highly specific to the pathology,
but also ever-present proteins that can be altered during
the progression of several unspecific processes such as in-
flammation, immune response, cellular death/proliferation,
etc. The possible biomarker value of these proteins is
exemplified by a recent work unravelling the key role of
complement dysregulation in OA pathogenesis [23]. Fur-
thermore, the identification in the present study of several
proteins related with the lipid metabolism might be rele-
vant for the definition of a new phenotype termed ‘meta-
bolic OA’, which is recently acquiring more attention in
the research community [24].
Osteoarthritis patients display an altered haptoglobin
protein profile in serum
Interestingly, we detected three spots corresponding to
the same protein accession number that exhibited differ-
ent alterations in OA sera when compared to controlern blot analyses of independent samples. (A) Representative image
thereof for Haptoglobin beta chain (HPT, which was increased in OA
d controls (N, n = 15) were resolved by SDS-PAGE and probed with
sity of Ponceau staining (upper figure). (C) Semi-quantitative
ta chain in OA sera.
Fernández-Costa et al. Proteome Science 2012, 10:55 Page 9 of 12
http://www.proteomesci.com/content/10/1/55(two increased and the other decreased, with 1.5 to 2-
fold variations). They were all identified as haptoglobin
precursor (HPT, P00738) in the Mascot search, and the
spot that was detected as increased in OA with a MW of
around 35 KDa is illustrated in Figure 6A. HPT precur-
sor is an N-linked glycoprotein [25] known to be cleaved
into two chains (alpha and beta, see Additional file 3:
Figure S2), which combine with free plasma hemoglobin
and contribute to the maintenance of cellular iron
homeostasis. Previous proteomic studies on synovial
fluid, also performed using 2D-gels, reported remarkable
interindividual differences in the haptoglobin patterns of
the studied patients [26,27]. In the present study, how-
ever, we did not analyze individual samples, but pools
made from 10 patients each. This strategy has proved its
usefulness in our previous iTRAQ-based approach [21],
and in the present work it has allowed the detection of
changes in HPT chains with a high statistic significance.
Nevertheless, we pursued also to verify the alteration of
HPT protein pattern in OA sera by an orthogonal strat-
egy, performing Western blot analyses on 30 new indi-
vidual samples from OA and control donors (n = 15
from each condition). As shown in Figure 6B, a remark-
able increase of the HPT beta chain (detected with a
molecular weight around 35–40 kDa) can be detected in
OA sera. We relatively quantified this increase as 2.22-
fold by densitometric analysis of the blots, p = 0.017
(Figure 6C). Although the relationship of HPT poly-
morphisms with diseases such as cancer or rheumatoid
arthritis has been largely studied due to the antioxidant
[28], anti-inflammatory [29] and immunomodulatory
properties [30] of this protein, this is the first time an al-
teration of HPT protein pattern is reported in OA.
Conclusions
In summary, we show in this work the application of a
novel sequential depletion procedure for the search of
osteoarthritis biomarkers in serum. This strategy has
been coupled to a DIGE-based quantitative proteomic
analysis, in order to find protein isoforms or fragments
that are specific of the disease. By these means, we were
able to identify 16 protein forms altered in the disease.
Among these, we verified for the first time the OA-
dependent increase of an haptoglobin chain. These data
demonstrate the usefulness of the approach for protein
biomarker discovery, and provide a list of potential OA
biomarker candidates that might be subject of further
validation studies.
Methods
Serum samples
The sera used for this study were obtained from OA
patients and controls with no history of joint disease,
which were characterized radiographically. Inclusioncriteria are fully described in a previous publication from
our group [31]. The patients meeting these criteria were
diagnosed with OA according to the American College
of Rheumatology (ACR) criteria, and knee and hip radio-
graphs from the participants were classified from grade I
to grade IV according to the Kellgren and Lawrence (K/L)
scoring system [32]. The patients were of both genders
and ages ranged from 58 to 90 years. A population of
20 samples from K/L grade IV and 20 non-symptomatic
controls was utilized for this study. Prior to proteomic
analysis, the serum samples were grouped into four pools
of 10 samples each to reduce individual and biolog-
ical variability. Table 1 summarizes the characteristics of
each pool.
Sequential depletion of high abundant proteins in serum
The sera were subjected to a sequential depletion proto-
col involving two precipitation steps (Figure 1): protein
depletion was first performed with DTT according to
the protocol described by Warder et al. [7] with minor
modifications, and then further depleted with ACN
according to Kay et al. [6]. With this aim, 2.2 μl of
500 mM DTT were added to 20 μl of pooled serum and
incubated for 1 h at room temperature until a viscous
precipitate persisted. This precipitate was pelleted by
centrifugation 2 × 20 min at 14000 × g. Subsequently,
the supernatant was transferred to a clean LoBind tube
and diluted with water prior to the addition of 57%
ACN [8]. Samples were briefly vortexed and sonicated
twice for 10 min. Then, ACN-precipitated proteins were
pelleted during 10 min at 14000 × g. Finally, the super-
natant was transferred to clean LoBind tubes and evapo-
rated to dryness in a Savant SPD121P SpeedVac
(Thermo, Waltham, USA) for further analysis.
Protein quantification
Precipitated proteins were solubilized in an isolectric
focusing-compatible lysis buffer containing 8 M urea,
2 M thiourea, 30 mM Tris and 4% CHAPS. The proteins
present in the pools were quantified (n = 5) using the
Bradford method (modified with HCl) [33]. A BSA
standard curve (0 to 4 mg/ml) and the samples were
analyzed in triplicate by reading at 570 nm in a micro-
plate reader (MultiskanW Plus, Labsystems, Quesada,
Argentina).
Protein labeling and two-dimensional electrophoresis
The proteomics comparison between osteoarthritic and
control sera was performed across four DIGE gels using
20 μg of total protein fraction per CyDye™ gel and two
biological replicates for each condition. Proteins in each
sample were fluorescently tagged with a set of matched
fluorescent dyes according to the manufacturer’s proto-
col for minimal labeling. To ensure that there were no
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swapped between two technical replicates of the same
sample, whereas the pooled standard sample was labeled
with Cy2. The standard pool was prepared by pooling
20 μg of proteins from each sample prior to labeling. In
every case, 160 pmol of dye was used for 20 μg of pro-
teins (8 pmol/μg). Labeling was performed for 30 min
on ice in darkness, and the reaction was quenched with
1 μl of 10 mM L-lysine for 10 min under the same
conditions.
The four pairs of Cy3- and Cy5-labeled samples (each
containing 20 μg of protein) were combined and mixed
with a 20-μg aliquot of the Cy2-labeled standard pool.
The mixtures, containing 60 μg of protein, were diluted
to 125 μl with rehydration buffer (7 M urea, 2 M thio-
urea, 4% CHAPS, 0.002% bromphenol blue, 2% ampho-
lytes (pH 3–11), and 97 mM Destreak reagent). Samples
were loaded onto IPG strips (7 cm, pH 4–7 non-linear)
by passive overnight rehydration. Isoelectric focusing
was carried out on a IPGphor II IEF system (GE Health-
care) using the following conditions: 333 Vhr at 500 V,
40 min at 1000 V and finally 9166 Vhr at 5000 V. Prior
to the second dimension run, the strips were equili-
brated first for 15 min in equilibration buffer (100 mM
Tris–HCl (pH 8.0), 6 M urea, 30% glycerol, and 2% SDS)
with 2% DTT and then for another 15 min in the same
buffer supplemented with 2.5% iodoacetamide and
0.002% bromophenol blue. The equilibrated strips were
transferred onto 12.5% homogenous polyacrylamide gels
(2.6% C) casted in low fluorescence glass plates. Electro-
phoresis was run at 150 V at 20°C.
Image acquisition and DIGE data analysis
The differentially labeled co-resolved proteins within each
gel were imaged at 100 dots/inch resolution using a DIGE
Imager scanner (GE Healthcare). Cy2-, Cy3-, and Cy5-
labeled images of each gel were acquired at excitation/
emission values of 488/520, 523/580, and 633/670 nm,
respectively. Gels were scanned directly between the glass
plates, and the 16-bit image file format images were
exported for data analysis. After imaging for CyDyes, the
gels were removed from the plates and stained with col-
loidal Coomassie following standard procedures.
Semi-automated image analysis was performed with
Progenesis SameSpots V3.2 software (Nonlinear Dynam-
ics). Multiplexed analysis was selected for DIGE experi-
ments and a representative gel image was chosen as
reference. Spots were detected and their normalized
volumes were ranked on the basis of ANOVA p-values
and fold changes.
Ultrasonic in-gel enzymatic digestion
The gel spots of interest were manually excised and
transferred to microcentrifuge tubes. Samples selectedfor analysis were subjected to ultrasonic in-gel enzymatic
digestion, according to the ultrafast proteolytic digestion
protocol previously described [34,35]. Briefly, protein
bands were washed with water and acetonitrile, reduced
with DTT and alkylated with IAA in an ultrasonic bath
(Sonorex RK 31 H, Bandelin, Berlin, Germany) operating
at 35 kHz (100% amplitude). Then, the gel was washed
again, dried and trypsin (375 ng in 25 μl) was added to
the dried protein bands. The in-gel protein digestion
was performed in a sonicator model SONOPULS HD
2200 (Bandelin, Berlin, Germany) operating at 50% amp-
litude for 2 min. Finally, supernatants were collected and
further peptide extraction was performed on the
remaining gel piece with acetonitrile 50% V/V, trifluor-
oacetic acid 0.1%V/V during 2 min at 50% amplitude in
the sonicator. Supernatants were pooled, evaporated to
dryness and reconstituted in 5 μl of formic acid 0.3% V/V.
Mass spectrometry (MS) analysis
The samples were analyzed using the Matrix-assisted
laser desorption/ionization (MALDI)-Time of Flight
(TOF)/TOF mass spectrometer 4800 Proteomics
Analyzer (ABSCIEX, MA, USA) and 4000 Series Ex-
plorer™ Software (ABSCIEX). Data Explorer version 4.2
(ABSCIEX) was used for spectra analyses and generating
peak-picking lists. All mass spectra were internally cali-
brated using autoproteolytic trypsin fragments and ex-
ternally calibrated using a standard peptide mixture
(Sigma-Aldrich). TOF/TOF fragmentation spectra were
acquired by selecting the 20 most abundant ions of each
MALDI-TOF peptide mass map (excluding trypsin auto-
lytic peptides and other known background ions). An
average of 2000 laser shots were employed per fragmen-
tation spectrum.
Database search
The amino acid sequence tags obtained from each pep-
tide fragmentation in MS/MS analyses were used to
search for protein candidates using Mascot version 2.2
from Matrix Science (http://www.matrixscience.com).
Peak intensity was used to select up to 50 peaks per pre-
cursor for MS/MS identification. Tryptic autolytic frag-
ments, keratin and matrix-derived peaks were removed
from the dataset used for the database search. The
searches for peptide mass fingerprints and tandem MS
spectra were performed in the SwissProt knowledge-
base (2011_05 release version, June 2011), by searching
in the UniProtKB/Swiss-Prot (http://www.expasy.ch/sprot)
database, containing 528048 sequences and 186939477
residues, with taxonomy restriction (Homo sapiens, 20239
sequences). Fixed and variable modifications were con-
sidered (Cys as S-carbamidomethyl derivate and Met as
oxidized methionine, respectively), allowing one trypsin
missed cleavage site and a mass tolerance of 50 ppm. MS
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http://www.proteomesci.com/content/10/1/55identifications were accepted as positive when at least
five peptides matched and at least 20% of the peptide
coverage of the theoretical sequences matched within a
mass accuracy of 50 or 25 ppm with internal calibration.
For MS/MS identifications, a precursor tolerance of
50 ppm and MS/MS fragment tolerance of 0.3 Da were
used. Probability scores were significant at p < 0.01 for all
matches.Western blot analysis
One-dimensional Western blot tests were performed
according to standard procedures. Briefly, 40 μg of serum
proteins were loaded and resolved on standard 15% po-
lyacrylamide SDS-PAGE gels. Separated proteins were
then electroblotted onto PVDF membranes (Immobilon P,
Millipore, Bedford, MA). Equivalent loadings were verified
by Ponceau Red staining after transference. Membranes
were blocked in Tris-buffered saline (pH 7.4) containing
0.1% Tween 20 (TBST) and 5% non-fat dried milk for
60 min at room temperature. The blots were then hybri-
dized overnight at 4°C with monoclonal antibodies against
the beta chain of HPT (ab13429, 1:500 dilution, Abcam,
Cambridge, UK), diluted in TBST with 2% nonfat milk.
After thorough washing with TBST, immunoreactive
bands were detected by chemiluminescence using the cor-
responding horseradish peroxidase-conjugated secondary
antibodies and ECL detection reagents (GE Healthcare),
and then digitized using an LAS 3000 image analyzer.
Quantitative changes in band intensities were evaluated
with ImageQuant 5.2 software (GE Healthcare). The den-
sitometry values of the Western blot bands containing the
HPT were normalized against those of Ponceau staining
obtained from the same membranes. Then, the relative
abundance of HPT was calculated by obtaining the ratio
of the normalized densitometric values between normal
and OA samples. Statistical p values of the densitometry
data were obtained by application of Mann–Whitney U
test using SPSS version 15.0 program.Additional files
Additional file 1: Figure S1. Representative 2D map of the sequentially
depleted serum, with the protein identifications that were carried out.
Identifications are listed in Additional file 2: Table S1.
Additional file 2: Table S1. Mass spectrometry data of the protein
identifications performed in the present study. Spot numbers, according
to Additional file 1: Figure S1.
Additional file 3: Figure S2. Amino acid sequence of Haptoglobin,
with the MS data corresponding to the identification of alpha and beta
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